+611.4%
ABBV vs THC
+1,506.5%
-895.1%
-45.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | -3.8% | +1.5% | -1.9% |
| 7D | -3.0% | -7.4% | +4.3% | -2.2% |
| 30D | +1.2% | +1.9% | -0.7% | +0.9% |
| 3M | +11.1% | +0.4% | +10.7% | +11.0% |
| 6M | +38.4% | +41.0% | -2.6% | +32.9% |
| YTD | +28.9% | +36.5% | -7.6% | +23.7% |
| 1Y | +26.0% | +40.6% | -14.6% | +20.4% |
| 3Y | +128.5% | +325.7% | -197.2% | +90.0% |
| 5Y | +191.8% | +245.0% | -53.2% | +141.6% |
| All | +611.4% | +1,506.5% | -895.1% | +357.1% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling